Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies. - Kievit, W; Fransen, J; Adang, EM (Ann Rheum Dis, 2009)
et al.